Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Infection and Immunity|March 1, 1980
Measles-specific antibodies in sera and cerebrospinal fluids of patients with multiple sclerosisE C Hayes, S D Gollobin, C E Machamer, et al.Infection and Immunity|December 1, 1984
Immunity against infection with Trypanosoma cruzi in mice correlates with presence of antibodies against three trypomastigote polypeptidesH J Zweerink, H D Weston, O F Andersen, et al.Cytotechnology|January 1, 1990
Heterohybridomas that secrete high levels of pseudomonas-specific therapeutic human monoclonal antibodies: their generation and large scale growth in an automated hollow fiber cell culture systemM C Gammon, M H Banas, L E Boccumini, et al.Infection and Immunity|March 1, 1980
Antibodies against the measles matrix polypeptide after clinical infection and vaccinationC E Machamer, E C Hayes, S D Gollobin, et al.Experimental Hematology|September 1, 1988
Suppression of in vitro granulocytopoiesis by captopril and penicillamineW P Hammond, J E Miller, G Starkebaum, et al.Infection and Immunity|June 1, 1978
Measles virus nucleocapsids: large-scale purification and use in radioimmunoassaysP M Moore, E C Hayes, S E Miller, et al.The Journal of Infectious Diseases|July 1, 1990
A human monoclonal antibody that protects mice against Pseudomonas-induced pneumoniaH J Zweerink, L J Detolla, M C Gammon, et al.Biochemical Pharmacology|October 1, 1985
In vivo and in vitro inhibition of human histidine decarboxylase by (S)-alpha-fluoromethylhistidineA S Tung, J T Blake, I J Roman, et al.International Journal of Immunopharmacology|January 1, 1990
Steroidal glycolipid, L-644,257, is a potent enhancer of nonspecific host resistanceW K Hagmann, M M Ponpipom, J J Jackson, et al.Journal of Medicinal Chemistry|February 1, 1990
Glycolipids as host resistance stimulatorsM M Ponpipom, W K Hagmann, L A O'Grady, et al.Pageof 4